Q. What is Lipid-lowering Trial?

Aggressive lipid-lowering drug treatment of persons at various risk levels reduces Coronary Artery Disease morbidity and mortality rates and increases overall survival rate. Although the association between hyperlipidemia and Coronary Artery Disease was established much earlier, the demonstration of a reduction in all cause mortality had to await the development of 3-hydroxy-3-methylglutaryl coenzyme a (HMG CoA) reductase inhibitors or statins.